| Literature DB >> 23380739 |
Kyoung-Ran Kim1, Da-Rae Kim, Taemin Lee, Ji Young Yhee, Byeong-Su Kim, Ick Chan Kwon, Dae-Ro Ahn.
Abstract
A DNA tetrahedron is employed for efficient delivery of doxorubicin into drug-resistant breast cancer cells. The drug delivered with the DNA nanoconstruct is considerably cytotoxic, whereas free doxorubicin is virtually non-cytotoxic for the drug-resistant cells. Thus, the DNA tetrahedron, made of the inherently natural and biocompatible material, can be a good candidate for the drug carrier to overcome MDR in cancer cells.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23380739 DOI: 10.1039/c3cc38693g
Source DB: PubMed Journal: Chem Commun (Camb) ISSN: 1359-7345 Impact factor: 6.222